To answer this question, we grew patient-derived GBM (08-387) tumorspheres in suspension, then fixed the spheres and immunolabeled for KIF11 and the primary cilia markers Arl13b and Cep135 to mark both the axoneme and basal body/centrosome, respectively. This evidence concerns the gene KIF11 and glioblastoma.